Zoledronic acid combined with adjuvant endocrine therapy of tamoxifen versus anastrozol plus ovarian function suppression in premenopausal early breast cancer: final analysis of the Austrian Breast and Colorectal Cancer Study Group Trial 12
Titel:
Zoledronic acid combined with adjuvant endocrine therapy of tamoxifen versus anastrozol plus ovarian function suppression in premenopausal early breast cancer: final analysis of the Austrian Breast and Colorectal Cancer Study Group Trial 12
Auteur:
Gnant, M. Mlineritsch, B. Stoeger, H. Luschin-Ebengreuth, G. Knauer, M. Moik, M. Jakesz, R. Seifert, M. Taucher, S. Bjelic-Radisic, V. Balic, M. Eidtmann, H. Eiermann, W. Steger, G. Kwasny, W. Dubsky, P. Selim, U. Fitzal, F. Hochreiner, G. Wette, V. Sevelda, P. Ploner, F. Bartsch, R. Fesl, C. Greil, R.